Toxicovigilance: a new approach for toxicological screening, quality control and regulation of irrational herbal drugs
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i01.pp33-35Abstract
Herbal medicines are now in great demand in the developing world for primary health care not because they are inexpensive but also for better cultural acceptability, better compatibility with the human body and minimal side effects. However, recent findings indicate that all herbal medicines may not be safe as severe consequences are reported for some herbal drugs. Most herbal products on the market today have not been subjected to drug approval process to demonstrate their safety and effectiveness. Thus, toxicovigilance can contribute for toxicological screening, quality control and regulation of herbal drugs including hazard identification and risk assessment by providing medically validated data which are often overlooked in the process of risk assessment. As pharmacist and researchers continue to explore the safety and effectiveness of herbal medicines, more is learned about both their promises and their pitfalls. At the same time, legislators at the national level should continue to press for effective laws to protect consumers from potentially harmful herbal drugs.
Keywords:
Toxicovigilance, ADR of Herbal drugs, Quality control, PharmacovigilanceDownloads
References
http://www.who.int/ipcs/poisons/centre/toxic ovigilance/en/ .
Jacques D, Franc OT: Toxicovigilance: A new approach for the hazard identification and risk assessment of toxicants in human beings. Toxicology and Applied Pharmacology 2005; 207, 599 – 603.
Akerele O: Herbal Gram 1993, 28, 13. , JIPBS, Vol 3 (1), 033-035, 2016
Blumenthal M., Brusse WR. Goldberg A., Gruenwald J., Hall T., Riggins CW and Rister, RS : The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. The American Botanical Council 2005; Austin, TX, 1998.
WHO Guidelines on Good Agricultural and Collection Practices (GACP). World Health Organization, Geneva.
Gaedcke F., Steinhoff B: Herbal Medicinal Products. Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation 2005. CRC Press, Boca Raton.
Ahmad FA; and M. Owais: Modern Phytomedicine. Turning Medicinal Plants into Drugs. Zeisel SH. Science 1999; 285, 1853. 144.
Petrovick PR., Marques LC., Paula IC: Alternative Health Care: The Canadian Directory. J . Ethnopharmacol 1999 ; 66, 51.
Pal SK., Shukla Y: Herbal medicine: current status and the future. Asian J. Cancer Prev, 2003; 4, 281.
WHO. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine 2000; World Health Organization, Geneva.
Mukherjee PK., Verpoorte R: GMP for Botanicals: Regulatory and Quality Issues on Phytomedicines. Business Horizons, New Delhi. 2003.
Moore B., Adler R: Pediatrics. 2000, 106, 600.
McRae S: Herbal and Traditional Medicine: Molecular Aspects of Health. Can. Med. Assoc. J. 1996; 155, 293.
Desmet, P.A.G.M; Keller K., Hansel R., Chandler RF : Adverse Effects of Herbal Drugs. Springer-Verlag, Heidelberg 1997; 3,145.
http://faculty.ksu.edu.sa/23494/documents/q uality%20control%20of%20herbal%20drugs .pdf .
Vikas D et al. Journal, Indian Academy of Clinical Medicine 2003; Vol. 4, No. 4, 345347.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Neetesh K Jain, Suman Jain, S.C. Mehta, S.D.Tonpay

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at